We are analyzing https://link.springer.com/article/10.1007/s00280-016-3213-5.

Title:
Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells | Cancer Chemotherapy and Pharmacology
Description:
A large number of studies have investigated possible drug resistance mechanisms of cancer cells and suggested strategies to overcome it. In this review, we outline the role and function of aldehyde dehydrogenase (ALDH) activity in multiple cellular functions and in cancer stem cells (CSCs) and focus on the role of retinoic acid (RA), one of the products of ALDH isozymes. We discuss our observation that ATRA and other RAs can suppress ALDH activity and decrease different ALDH isozyme proteins and result in detrimental effects on cell proliferation, invasion and chemotherapy sensitivity. We review the known uses of different RAs in the treatment of cancers. We review the use of RAs in combination with chemo-/radiotherapy and the major signaling pathways affected in different tumor types. We provide follow-up on studies that may have used our prior observation with the aim of targeting the CSCs. We conclude with summary of the findings and potential impact of published studies on future use of RAs in the targeting of CSCs and drug resistance.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,603,724 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

pubmed, article, google, scholar, cancer, cas, cells, stem, acid, aldehyde, retinoic, dehydrogenase, central, cell, aldh, treatment, chemotherapy, drug, alltrans, moreb, res, resistance, leukemia, human, acute, oncol, therapy, role, activity, rev, ther, lung, potential, review, combination, access, expression, pharmacol, promyelocytic, trial, patients, phase, privacy, cookies, content, retinoids, results, med, neuroblastoma, study,

Topics {✒️}

month download article/chapter cd133+ tumor-initiating cells aids-related cutaneous kaposi enhances dexamethasone-induced cytotoxicity therapy-resistant cancer cells c-myc antisense dna peroxisome proliferator-activated receptor small-cell lung cancer downregulating c-myc expression aldehyde dehydrogenase class-1a1 article cancer chemotherapy potential targeted therapy drug-resistant lung cancer trans retinoic acid trans-retinoic acid cancer stem cells high-dose combination chemotherapy ovarian cancer cells cellular retinoid-binding proteins full article pdf cancer therapeutics retinoic acid biosynthesis 13-cis-retinoic acid 9-cis-retinoic acid growth factor support stem cell properties human aldehyde dehydrogenase selectively targeting aldh-high retinoic acid receptors acute myeloid leukemia aldehyde dehydrogenase expression acute promyelocytic leukemia inhibits tumour formation privacy choices/manage cookies multiple myeloma cells regulates aldehyde dehydrogenase aldehyde dehydrogenase inhibitors article moreb rnai-mediated knockdown leukemic blasts defines metastatic breast cancer human aldehyde dehydrogenases aldehyde dehydrogenase gene aldehyde dehydrogenase activity randomized controlled trial moreb js author correspondence related subjects aldehyde dehydrogenase superfamily activity reduces chemotherapy

Questions {❓}

Pors K, Moreb JS (2014) Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells
         description:A large number of studies have investigated possible drug resistance mechanisms of cancer cells and suggested strategies to overcome it. In this review, we outline the role and function of aldehyde dehydrogenase (ALDH) activity in multiple cellular functions and in cancer stem cells (CSCs) and focus on the role of retinoic acid (RA), one of the products of ALDH isozymes. We discuss our observation that ATRA and other RAs can suppress ALDH activity and decrease different ALDH isozyme proteins and result in detrimental effects on cell proliferation, invasion and chemotherapy sensitivity. We review the known uses of different RAs in the treatment of cancers. We review the use of RAs in combination with chemo-/radiotherapy and the major signaling pathways affected in different tumor types. We provide follow-up on studies that may have used our prior observation with the aim of targeting the CSCs. We conclude with summary of the findings and potential impact of published studies on future use of RAs in the targeting of CSCs and drug resistance.
         datePublished:2016-12-10T00:00:00Z
         dateModified:2016-12-10T00:00:00Z
         pageStart:295
         pageEnd:301
         sameAs:https://doi.org/10.1007/s00280-016-3213-5
         keywords:
            Retinoic acid
            Aldehyde dehydrogenase
            Cancer stem cells
            Chemotherapy
            Oncology
            Pharmacology/Toxicology
            Cancer Research
         image:
         isPartOf:
            name:Cancer Chemotherapy and Pharmacology
            issn:
               1432-0843
               0344-5704
            volumeNumber:79
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jan S. Moreb
               url:http://orcid.org/0000-0001-9330-7500
               affiliation:
                     name:University of Florida
                     address:
                        name:Hematology/Oncology Division, Department of Medicine, University of Florida, Gainesville, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Deniz A. Ucar-Bilyeu
               affiliation:
                     name:LSU College of Medicine
                     address:
                        name:Genetics Department, LSU College of Medicine, New Orleans, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Abdullah Khan
               affiliation:
                     name:University of Florida
                     address:
                        name:Hematology/Oncology Division, Department of Medicine, University of Florida, Gainesville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells
      description:A large number of studies have investigated possible drug resistance mechanisms of cancer cells and suggested strategies to overcome it. In this review, we outline the role and function of aldehyde dehydrogenase (ALDH) activity in multiple cellular functions and in cancer stem cells (CSCs) and focus on the role of retinoic acid (RA), one of the products of ALDH isozymes. We discuss our observation that ATRA and other RAs can suppress ALDH activity and decrease different ALDH isozyme proteins and result in detrimental effects on cell proliferation, invasion and chemotherapy sensitivity. We review the known uses of different RAs in the treatment of cancers. We review the use of RAs in combination with chemo-/radiotherapy and the major signaling pathways affected in different tumor types. We provide follow-up on studies that may have used our prior observation with the aim of targeting the CSCs. We conclude with summary of the findings and potential impact of published studies on future use of RAs in the targeting of CSCs and drug resistance.
      datePublished:2016-12-10T00:00:00Z
      dateModified:2016-12-10T00:00:00Z
      pageStart:295
      pageEnd:301
      sameAs:https://doi.org/10.1007/s00280-016-3213-5
      keywords:
         Retinoic acid
         Aldehyde dehydrogenase
         Cancer stem cells
         Chemotherapy
         Oncology
         Pharmacology/Toxicology
         Cancer Research
      image:
      isPartOf:
         name:Cancer Chemotherapy and Pharmacology
         issn:
            1432-0843
            0344-5704
         volumeNumber:79
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jan S. Moreb
            url:http://orcid.org/0000-0001-9330-7500
            affiliation:
                  name:University of Florida
                  address:
                     name:Hematology/Oncology Division, Department of Medicine, University of Florida, Gainesville, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Deniz A. Ucar-Bilyeu
            affiliation:
                  name:LSU College of Medicine
                  address:
                     name:Genetics Department, LSU College of Medicine, New Orleans, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Abdullah Khan
            affiliation:
                  name:University of Florida
                  address:
                     name:Hematology/Oncology Division, Department of Medicine, University of Florida, Gainesville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Chemotherapy and Pharmacology
      issn:
         1432-0843
         0344-5704
      volumeNumber:79
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Florida
      address:
         name:Hematology/Oncology Division, Department of Medicine, University of Florida, Gainesville, USA
         type:PostalAddress
      name:LSU College of Medicine
      address:
         name:Genetics Department, LSU College of Medicine, New Orleans, USA
         type:PostalAddress
      name:University of Florida
      address:
         name:Hematology/Oncology Division, Department of Medicine, University of Florida, Gainesville, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jan S. Moreb
      url:http://orcid.org/0000-0001-9330-7500
      affiliation:
            name:University of Florida
            address:
               name:Hematology/Oncology Division, Department of Medicine, University of Florida, Gainesville, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Deniz A. Ucar-Bilyeu
      affiliation:
            name:LSU College of Medicine
            address:
               name:Genetics Department, LSU College of Medicine, New Orleans, USA
               type:PostalAddress
            type:Organization
      name:Abdullah Khan
      affiliation:
            name:University of Florida
            address:
               name:Hematology/Oncology Division, Department of Medicine, University of Florida, Gainesville, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Hematology/Oncology Division, Department of Medicine, University of Florida, Gainesville, USA
      name:Genetics Department, LSU College of Medicine, New Orleans, USA
      name:Hematology/Oncology Division, Department of Medicine, University of Florida, Gainesville, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(250)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.65s.

LINK . SPRINGER . COM {}